Thadani U, Davidson C, Singleton W, Taylor S H
N Engl J Med. 1979 Apr 5;300(14):750-5. doi: 10.1056/NEJM197904053001402.
We compared the immediate effects of five beta-adrenoreceptor-blocking agents in 16 patients with stable angina pectoris. Acute dose-response studies showed that all five drugs improved exercise tolerance and reduced ST-segment depression, heart rate and blood pressure by a similar degree in comparison with a placebo (P less than 0.01). Near maximum improvement in exercise tolerance occurred when the acute cumulative oral dose had reached 160 mg for propranolol and oxprenolol, 200 mg for metoprolol and tolamolol and 400 mg for practolol. When these drugs were administered as a single doses, increase in walking time before the development of angina and reduction in ST-segment depression, heart rate and systolic blood pressure all occurred within one hour and persisted for eight hours--effects markedly different from the response to a placebo (P less than 0.01). These data show that non-cardioselective agents (propranolol and oxprenolol), cardioselective agents (practolol, metoprolol and tolamolol), as well as drugs with intrinsic sympathomimetic activity (oxprenolol and practolol), were equally effective in the treatment of angina pectoris.
我们比较了5种β-肾上腺素能受体阻滞剂对16例稳定型心绞痛患者的即时效应。急性剂量反应研究表明,与安慰剂相比,所有5种药物均能以相似程度改善运动耐量、降低ST段压低、心率和血压(P<0.01)。当普萘洛尔和氧烯洛尔的急性累积口服剂量达到160mg、美托洛尔和托拉洛尔达到200mg、醋丁洛尔达到400mg时,运动耐量接近最大程度改善。当这些药物单次给药时,心绞痛发作前步行时间增加以及ST段压低、心率和收缩压降低均在1小时内出现并持续8小时——这些效应与对安慰剂的反应明显不同(P<0.01)。这些数据表明,非心脏选择性药物(普萘洛尔和氧烯洛尔)、心脏选择性药物(醋丁洛尔、美托洛尔和托拉洛尔)以及具有内在拟交感活性的药物(氧烯洛尔和醋丁洛尔)在治疗心绞痛方面同样有效。